Five-Year Follow-Up After Ibrutinib Therapy for First-Line Treatment of Chronic Lymphocytic Leukemia Burger, J., Tedeschi, A., Barr, P. M., Robak, T., Owen, C., Ghia, P., Bairey, O., Hillmen, P., Coutre, S. E., Devereux, S., Grosicki, S., McCarthy, H., Li, J., Simpson, D., Offner, F., Moreno, C., Dai, S., Lal, I., Dean, J. P., Kipps, T. J. CIG MEDIA GROUP, LP. 2019: S274

View details for DOI 10.1016/j.clml.2019.07.205

View details for Web of Science ID 000483480700243